Skip to main content
PMC home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2007 Sep;22(2):96–100. doi: 10.1007/BF02913323

Hospital based preliminary study on osteoporosis in postmenopausal women

V Indumati 1, Vidya S Patil 2,✉, Rama Jailkhani 2
PMCID: PMC3453808  PMID: 23105692

Abstract

The awareness of osteoporosis has grown world wide in recent years. This silently progressing metabolic bone disease is widely prevalent in India, and osteoporotic fractures are a common cause of morbidity and mortality in adult Indian men and women. Rapid bone loss occurs in postmenopausal women due to hormonal factors which lead to increased risk of fractures. Biochemical markers of bone metabolism are used to assess skeletal turnover. A cross-sectional study of 150 pre- and post menopausal women was carried out at S.D.M College of Medical Sciences and Hospital, Dharwad, during the period of May 2005 to September 2005. The study group consisted of 75 Premenopausal women in the age group of 25–45 years and 75 Postmenopausal women in the age group of 46–65 years. Bone formation markers (Total Calcium, lonised calcium, Phosphorus, Alkaline phosphatase), and bone resorption markers (Urinary Hydroxyproline) were analysed in pre and post menopausal women. Bone formation markers, Total and lonised calcium were significantly decreased (p<0.001) and Alkaline phosphatase was significantly increased (p<0.001) in postmenopausal women compared to premenopausal women. Bone resorption markers, Urinary hydroxyproline excretion was significantly increased (p<0.001) in postmenopausal women. The results from this study suggest that simple, easy, common biochemical markers can still be used to assess the bone turnover in postmenopausal women and hence their risk of developing osteoporosis and fractures.

Key Words: Postmenopausal osteoporosis, Urinary Hydroxyproline, Alkaline phosphatase

Full Text

The Full Text of this article is available as a PDF (69.9 KB).

References

  • 1.Simsek B, Karacaer O, Karaca I. Urine products of bone breakdown as markers of bone resorption and clinical usefulness of urinary hydroxyproline: an overview. Chin Med J. 2004;117(2):291–95. [PubMed] [Google Scholar]
  • 2.Vipla Puri. Biochemical Markers: Diagnostic Considerations and Clinical Applications for Osteoporosis Assessment. Bombay Hospital Journal. 2003: 45(2). http://www.bhj.org/journal/2003_4502_april/biochemicalmarketrs_325.htm
  • 3.Gupta A. Osteoporosis in India—the nutritional hypothesis. Natl Med J Ind. 1996;9(6):268–74. [PubMed] [Google Scholar]
  • 4.Facts and statistics about osteoporosis and its impact. International osteoporosis Foundation Osteoporosis society of India, 2003 Action plan osteoporosis. Consensus statement of an expert group, New Delhi. http://www.osteofound.org/press_centre/fact_sheet.html
  • 5.Osteoporosis in postmenopausal women: Diagnosis and Monitoring. Summary, Evidence Report/Technology Assessment: No. 28. Agency for Healthcare Research and Quality Publication No. 01-E031, Feb 2001. http://www.ahrq.gov/clinic/epcsums/osteosum.htm
  • 6.Susan A. Calcium Supplementation in Postmenopausal Women. From Medscape Ob/Gyn & Women's health, 2003: 8(2) http://www.medscape.com/viewarticle/460438
  • 7.Delmas PD. Biochemical markers of bone turnover for the clinical investigation of osteoporosis. Osteoporos Int. 1993;3(1):81–6. doi: 10.1007/BF01621873. [DOI] [PubMed] [Google Scholar]
  • 8.Woitge HW, Nave CS, Kissing C, Bruckner GL, Meyer K, Grauer A, et al. Seasonal Variation of Biochemical Indexes of Bone Turnover; Results of a population-based Study. J Clin Endocrinol Metab. 1998;92(1):68–75. doi: 10.1210/jc.83.1.68. [DOI] [PubMed] [Google Scholar]
  • 9.Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J. The Use of Biochemical Markers of Bone Turnover in Osteoporosis. Osteoporos Int. 2000;Suppl 6:2–17. doi: 10.1007/s001980070002. [DOI] [PubMed] [Google Scholar]
  • 10.Watts NB. Clinical utility of biochemical markers of bone remodeling. Clin Chem. 1999;45(8):1359–68. [PubMed] [Google Scholar]
  • 11.Kleerekoper M. Biochemical markers of Bone Turnover: Why Theory, Research, and Clinical practice Are Still in Conflict. Clin Chem. 2001;47:1347–9. [PubMed] [Google Scholar]
  • 12.Gotfredsen A, Westergren HH, Andersen T. Influence of orlistat on bone turnover and body composition. Int J Obes Relat Metab Disord. 2001;25:1154–60. doi: 10.1038/sj.ijo.0801639. [DOI] [PubMed] [Google Scholar]
  • 13.Gitelman HJ. An Improved automatic procedure for the determination of Calcium in biologic specimens. Anal Biochem. 1967;18:521–31. doi: 10.1016/0003-2697(67)90110-8. [DOI] [Google Scholar]
  • 14.Isselbacher KJ, Braunwad E, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrison's Principles of Internal Medicine, 13th Ed. Vol 2, Mc Graw-Hill publication, 1994, 2139 pp
  • 15.Daly JA, Ertingshausen G. Direct Method for Determining Inorganic Phosphate in Serum with the “CentrifiChem”. Clin Chem. 1972;18(3):263–5. [PubMed] [Google Scholar]
  • 16.McMurray JR. Plasma Proteins. In: Gowenlock AH, editor. Varley's Practical clinical Biochemistry. 6th ed. New Delhi: CBS publishers (Indian Reprint); 2002. pp. 407–8. [Google Scholar]
  • 17.Varley H, editor. The Plasma Proteins: In Practical clinical Biochemistry. 4th ed. New Delhi: CBS publishers (Indian Edition); 1988. pp. 243–4. [Google Scholar]
  • 18.Henry RJ, editor. Enzymes: In Clinical Chemistry Principle and techniques. New York: Harper and Row publishers; 1974. [Google Scholar]
  • 19.Mitoma C, Smith TE, Davidson JD, Udenfriend S, Dacosta FM. Sjoerdsma, Bethesda. Improvements in methods for Measuring hydroxyproline. J Lab Clin Med. 1959;53(6):970–6. [PubMed] [Google Scholar]
  • 20.Varley H, editor. Non Protein Nitrogen: In Practical clinical Biochemistry. 4th ed. New Delhi: CBS publishers (Indian Edition); 1988. pp. 197–8. [Google Scholar]
  • 21.Justesen TI, Petersen JLA, Ekbom P, Damm P, Matheisen ER. Albumin-to-Creatinine ratio in random urine samples might replace 24-h urine collections in screening for Micro-and Macroalbuminuria in pregnant women with Type-1 Diabetes. Diabetes Care. 2006;29(4):924–5. doi: 10.2337/diacare.29.04.06.dc06-1555. [DOI] [PubMed] [Google Scholar]
  • 22.George BO. Urinary and Anthropometrical Indices of Bone Density in healthy Nigerian Adults. J Appl Sci Environ Mgt. 2003;7(1):19–23. [Google Scholar]
  • 23.Lofman O, Magnusson P, Toss G, Larsson L. Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study. Clin Chim Acta. 2005;356:67–75. doi: 10.1016/j.cccn.2004.12.014. [DOI] [PubMed] [Google Scholar]
  • 24.Sachdeva A, Seth S, Khosla AH, Sachdeva S. Study of some common Biochemical bone turnover markers in post menopausal women. Ind J Clin Biochem. 2005;20(1):131–4. doi: 10.1007/BF02893058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Rosen CJ, Tenenhouse A. Biochemical markers of bone turnover. Postgraduate Medicine. 1998;104(4):101–18. doi: 10.3810/pgm.1998.10.447. [DOI] [PubMed] [Google Scholar]
  • 26.Mazzuoli G, Acca M, Pisani D, Diacinti D, Scarda A, Scarnecchia L, et al. Annual skeletal blance and metabolic bone marker changes in healthy early postmenopausal women: results of a prospective study. Bone. 2000;26(4):381–6. doi: 10.1016/S8756-3282(00)00242-8. [DOI] [PubMed] [Google Scholar]
  • 27.Rosa G, Testa A, Giacomini D, Carrozza C, Astazi P, Caradonna P. Prospective study of bone loss in pre- and post-menopausal women on L-thyroxine therapy for toxic goiter. Clin Endocrinol. 1997;47(5):529–35. doi: 10.1046/j.1365-2265.1997.3221125.x. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES